Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group
Ruta D. Rao, Melody A. Cobleigh, Robert Gray, Mark L. Graham, Larry Norton, Silvana Martino, George Thomas Budd, James N. Ingle, William C. WoodVolume:
28
Langue:
english
Pages:
9
DOI:
10.1007/s12032-010-9682-1
Date:
December, 2011
Fichier:
PDF, 281 KB
english, 2011